A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PGAs / prostaglandin analogs

[Related PubMed/MEDLINE]
Total Number of Papers: 57
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PGAs  (>> Co-occurring Abbreviation)
Long Form:   prostaglandin analogs
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Comparison of Prostaglandin Analog Treatment Patterns in Glaucoma and Ocular Hypertension. IOP, MPR
2019 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or beta-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis. AEs, b.i.d, b.i.d, IOP, OHT, t.i.d, t.i.d
2019 Ocular Surface Changes in Prostaglandin Analogue-Treated Patients. IOP
2019 Omidenepag isopropyl for the treatment of glaucoma and ocular hypertension. OHT
2019 Shortening of Interpupillary Distance after Instillation of Topical Prostaglandin Analog Eye Drops. IOPs, IPD, PAP
2019 Variation in Prostaglandin Analog Prices Paid for Through Medicare Part D. ---
2018 Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients. DED, IOP, OSDI, POAG
2018 In Vivo Analysis of Prostaglandins-induced Ocular Surface and Periocular Adnexa Modifications in Patients with Glaucoma. IOP, MGs, OS, SEs
2018 Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review. IOP, NTG
10  2018 Pretarsal skin height changes in children receiving topical prostaglandin analogue therapy for primary congenital glaucoma. PCG, PTSH
11  2018 Trends in the characteristics of vitrectomy in Eastern China. AAs, BBs, CAI-Ss, CAI-Ts, IOL, PPV
12  2018 Washout Duration of Prostaglandin Analogues: A Systematic Review and Meta-analysis. IOP, OHT, POAG
13  2017 Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients. BCVA, IOP, OAG/OH
14  2017 Does the intraocular pressure-lowering effect of prostaglandin analogues continue over the long term? IOP, POAG
15  2017 Factors Related to Prostaglandin-Associated Periorbitopathy in Glaucoma Patients. BMI, CIs, OHT, OR, PAP
16  2017 Glaucoma Medication Preferences among Glaucoma Specialists in Mexico. AA, BB, CAI
17  2017 Periocular mexametric melanin and erythema indexes in adult glaucoma patients treated with topical prostaglandin analogs. ---
18  2017 Periorbital changes associated with prostaglandin analogs in Korean patients. ---
19  2017 The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucoma. CCT, CH, CRF, IOP, POAG
20  2016 Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors. FP, IOP
21  2016 In vitro Effects of Prostaglandin Analogs on Cultured Astrocytes Obtained from the Lamina Cribrosa. BIM-A, LAT-A, LC, ONH, TdT
22  2016 Long-term assessment of prostaglandin analogs and timolol fixed combinations vs prostaglandin analogs monotherapy. FCs, IOP, RCTs
23  2016 Ocular Tolerability of Preservative-Free Tafluprost and Latanoprost: in vitro and in vivo Comparative Study. HCE-T, MGHS40, PF
24  2016 Vitamin A Palmitate and Carbomer Gel Protects the Conjunctiva of Patients With Long-term Prostaglandin Analogs Application. GCs
25  2016 [Quantitative evaluation of uveoscleral outflow for optimization of glaucoma treatment]. POAG
26  2015 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study. ---
27  2015 Fixed-combination treatments for intraocular hypertension in Chinese patients - focus on bimatoprost-timolol. BTFC, IOPs
28  2015 Medical therapy for glaucoma: what to add after a prostaglandin analogs? IOPs
29  2015 Trends in Glaucoma Medication Expenditures under Universal Health Coverage: A National Population-Based Longitudinal Survey in Taiwan. ---
30  2014 Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs. ---
31  2014 Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension. IOP, RRs
32  2014 Effectiveness of the ICare rebound tonometer in patients with overestimated intraocular pressure due to tight orbit syndrome. GAT, IOP
33  2014 Efficacy and tolerability of mono-compound topical treatments for reduction of intraocular pressure in patients with primary open angle glaucoma or ocular hypertension: an overview of reviews. CAI, IOP, OHT, POAG
34  2013 Acute effects of glaucoma medications and benzalkonium chloride on pre-adipocyte proliferation and adipocyte cytotoxicity in vitro. BAK
35  2013 Efficacy of timolol 0.1% gel and a prostaglandin 
analog in an unfixed combination compared to the corresponding fixed combinations. IOP, POAG
36  2013 Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases. ---
37  2013 In vivo confocal microscopy of meibomian glands in glaucoma. BUT, LSCM, MAD, MGs, OSDI, PF, STI
38  2013 Prostaglandin analogs and timolol-fixed versus unfixed combinations or monotherapy for open-angle glaucoma: a systematic review and meta-analysis. IOP, MeD, MT, RR, UC
39  2013 The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes. CCT, CH, CRF, GAT, IOP, ORA
40  2012 A prospective study evaluating IOP changes after switching from a therapy with prostaglandin eye drops containing preservatives to nonpreserved tafluprost in glaucoma patients. ---
41  2012 Comparison of efficacy of four prostaglandin analogues by bilateral treatment in healthy subjects. IOP
42  2012 Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma. LTP
43  2012 Intraocular pressure-lowering combination therapies with prostaglandin analogues. IOP
44  2012 Meta-analysis of alpha2-adrenergic agonists versus carbonic anhydrase inhibitors as adjunctive therapy. AA, BBs, CAIs, IOP, OHT, POAG, WMD
45  2012 The influence of central corneal thickness on response to topical prostaglandin analogue therapy. CCT, IOP
46  2011 Additive intraocular pressure-lowering effect of dorzolamide 1%/timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma. IOP, PGs
47  2011 Balancing efficacy and tolerability of prostaglandin analogues and prostaglandin-timolol fixed combinations in primary open-angle glaucoma. IOP
48  2010 In vitro toxicity of topical ocular prostaglandin analogs and preservatives on corneal epithelial cells. BAK, BSS
49  2010 Physicians' treatment decisions, patient persistence, and interruptions in the continuous use of prostaglandin therapy in glaucoma. ---
50  2010 The intraocular pressure-lowering effect of prostaglandin analogs combined with topical beta-blocker therapy: a systematic review and meta-analysis. BB, IOP
51  2009 Effect of bimatoprost, latanoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human ciliary body smooth muscle cells. CBSM, ECM, MMP, TIMPs
52  2009 From the bedside to the bench and back again: predicting and improving the outcomes of SLT glaucoma therapy. IOP, SCEs, SLT, TMEs
53  2008 Changes in central corneal thickness over time: the ocular hypertension treatment study. CCT, OHTS
54  2008 The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: a systematic review. AEs, IOP, RCTs
55  2008 [Retina and glaucoma: therapeutic considerations]. CME, IOP
56  2007 Glaucoma: a review of adjunctive therapy and new management strategies. CAIs, IOP
57  2005 Management of glaucoma: focus on pharmacological therapy. CAIs, IOP